Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS
about
Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteinsMerging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseNeuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsParkinson's disease: gene therapiesCell-type specific expression of the vasopressin gene analyzed by AAV mediated gene delivery of promoter deletion constructs into the rat SON in vivoDrug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy.Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo.New small molecules for the treatment of Parkinson's disease.Current status of non-viral gene therapy for CNS disorders.Gene delivery with viral vectors for cerebrovascular diseases.Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke modelDelayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's diseaseAutofluorescent cells in rat brain can be convincing impostors in green fluorescent reporter studiesMonocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.Cell-type specific expression of oxytocin and vasopressin genes: an experimental odysseyC3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury.MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.Role of oxidative stress in refractory epilepsy: evidence in patients and experimental models.Differential Cellular Tropism of Lentivirus and Adeno-Associated Virus in the Brain of Cynomolgus MonkeyExercise leads to the re-emergence of the cholinergic/nestin neuronal phenotype within the medial septum/diagonal band and subsequent rescue of both hippocampal ACh efflux and spatial behaviorDiffusion of macromolecules in the brain: implications for drug delivery.Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN DeficiencyBiodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the BrainCDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.Assembly of protein-based hollow spheres encapsulating a therapeutic factorResearch advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.Drug delivery systems for the treatment of ischemic stroke.Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indicationsCorticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.Inorganic nanovectors for nucleic acid delivery.The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system.AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models.Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.Cell replacement therapy is the remedial solution for treating Parkinson's disease.Gene Manipulation Strategies to Identify Molecular Regulators of Axon Regeneration in the Central Nervous System.Long-term expression of miRNA for RNA interference using a novel vector system based on a negative-strand RNA virus.Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson's disease.
P2860
Q26750915-F2496A30-1A41-4585-9560-16102680C237Q26773485-E2F3697C-9A96-4666-944E-15A923E05138Q26777286-2A1F87E2-4468-49F9-B200-D79D3821EACAQ26824184-67429E41-1A66-49DB-9780-9A12C674D423Q27340137-7DA0C7DE-0BF5-4C30-80F0-2AE646233713Q30424484-557C2EBF-A33A-4B50-A22D-0E1A1A68F116Q31049117-F9A7C9CA-0BC6-4CF1-85CB-0CA5622AB878Q33636631-E35DAB5C-66E4-406D-A0F0-5F25DD3DC234Q33824159-239C4B39-DA1C-4F78-8201-F3F51E08526FQ33917592-34AE7C80-E037-456A-8C74-5D22E8E9F386Q34078114-DCFECA8D-4C59-4D8C-B412-2EC2A0D58CF6Q34420401-9D9070D2-5EB8-4641-9EEE-C90D9601A731Q34473323-FC91E46E-7DEB-498A-9FC2-415848E59524Q34997042-B592193B-664D-4DDA-B994-FBD0830E5FBDQ35088011-2999939E-618D-401F-B196-7C88315E0F8DQ35685561-9F104209-67F8-47BD-868D-E521C9AF98F4Q35729655-A3D9EACE-7345-4218-BA7B-87B34EC959EBQ36157573-A45AA9C1-F1E0-46D9-942F-8E209886C1B8Q36590070-D8D71ED2-441D-49F1-97AF-9660CFB3FFE8Q36614768-AF2904B4-2803-4A62-9568-AC8943D77B36Q36694301-70771DAE-3EB9-40EB-AC07-EF9A34EBA3CAQ36823757-FAF43D35-EC81-42F3-A347-0594862D0F67Q36939767-D2F0BDA6-5905-4389-926D-D4608083EE13Q37019334-45F63AE5-A67D-4DD3-B44F-068600CA3FB1Q37121244-B5FAD310-6ADF-40AA-B2ED-C3B288238810Q37186189-5EC536E4-311E-44CF-882B-9C503ED17731Q37957674-95470C0C-C899-409D-927D-BCE7E3E42C57Q38073181-6C921DCF-B717-49EB-8AB5-4C7A8BFAB75CQ38073714-42167B37-2B34-4378-8126-DDE881136524Q38166648-D52FC1CA-6E1A-45E4-9E09-E40115F8D6F5Q38256020-A0A40EDB-C913-4F44-B91C-28815C633D59Q38383483-178AA0EC-D076-49CC-8D23-F508FD897976Q38438132-74CD0033-B288-41F9-8AAA-1A348716EB1FQ39139260-A5CC69D1-D8E0-4EA0-B935-86DC2E18910AQ39197908-85F35864-63E1-4E75-B935-5534E00E191EQ39446547-3FF688C1-3DC2-4488-8441-51F6F8A68009Q40077177-ACE85A62-F2F2-4EDB-A8EB-2233CA49706EQ40670785-63ACAF4A-76D2-4746-BB47-CBF08440BB20Q42200227-8B88B376-6632-4FA2-B284-0B3356B64DE4Q42839842-E5EE6C02-E6EB-4DA6-9E5D-FDAA98C886A7
P2860
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Viral vectors for neurotrophic ...... generative diseases of the CNS
@ast
Viral vectors for neurotrophic ...... generative diseases of the CNS
@en
type
label
Viral vectors for neurotrophic ...... generative diseases of the CNS
@ast
Viral vectors for neurotrophic ...... generative diseases of the CNS
@en
prefLabel
Viral vectors for neurotrophic ...... generative diseases of the CNS
@ast
Viral vectors for neurotrophic ...... generative diseases of the CNS
@en
P2860
P921
P1476
Viral vectors for neurotrophic ...... generative diseases of the CNS
@en
P2093
Seung T Lim
P2860
P356
10.1016/J.PHRS.2009.10.002
P577
2009-10-17T00:00:00Z